Analysis of Clinical Nutrition Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Worldwide revenue from the demand for clinical nutrition market is estimated to stand at US$ 15.48 billion in 2024 and is slated to increase at a CAGR of 5.3% to reach US$ 25.94 billion by 2034. Chronic diseases requiring clinical nutritional care are becoming more common over time. These include Alzheimer's disease, Attention Deficit Hyperactivity Disorder (ADHD), osteoporosis, osteoarthritis, abnormalities of the central nervous system, and other ailments. For example, according to statistics released by the Centers for Disease Control and Prevention (CDC) in August 2023, attention deficit hyperactivity disorder (ADHD) is one of the most common mental health disorders in children, with 6 million children between the ages of 3 and 17 having been diagnosed with the disorder at some time. In a similar vein, a paper in November 2022 in the International Journal of Child Development and Mental Health suggested that Thailand has a higher-than-normal prevalence of ADHD, ranging from 4.2% to 8.1%. Manufacturers are being encouraged by the increasing prevalence of ADHD to provide improved therapeutic nutrition solutions that meet patients' dietary needs. For example, SFI Health introduced EQUAZEN PRO in January 2021. It helps kids and teenagers with ADHD and other neurodiverse disorders focus, study, and maintain healthy brain function.
| Report Attribute | Detail |
|---|---|
| Clinical Nutrition Market Size (2024E) | US$ 15.48 Billion |
| Forecasted Market Value (2034F) | US$ 25.94 Billion |
| Global Market Growth Rate (2024 to 2034) | 5.3% CAGR |
| East Asia Market Value (2034F) | US$ 5.99 Billion |
| North America Market Share (2034F) | 24.3% |
| Infant Nutrition Segment Value (2034F) | US$ 10.07 Billion |
| United States Market Value (2034F) | US$ 2.87 Billion |
| Key Companies Profiled | Danone (Nutricia); Abbott Nutrition; Grifols, S.A.; Pfizer Inc.; Baxter; Meiji Holdings. Co., Ltd.; Bayer AG; Fresenius Kabi; Nestle; Abbvie (Allergan); Mead Johnson & Company, LLC; Baxter International Inc.; Victus, Inc.; Otsuka Holdings Co., Ltd. |
Over the past few years, there has been a noticeable increase in the population of elderly people with serious diseases. Because of several age-related changes in body composition and muscle mass, the risk of malnutrition and frailty is significantly higher among the older population with comorbidities, such as stroke, depression, and dementia. The frequency of malnutrition in hospitalized patients varies greatly, ranging from 20% to 50%, depending on the precise diagnostic criteria and screening methods used, according to an NCBI study published in February 2022. As a result, experts are taking full advantage of clinical nutrition alternatives for senior citizens, which is having the potential to drive the market throughout the projected period.
The longer life expectancy is contributing to the growing body of evidence linking diet to overall health. More individuals are paying greater attention to longevity and are more conscious of the health hazards (cancer, diabetes, and cardiovascular disorders) that are shortening their lives. It is well known that eating a balanced diet encourages good aging, and making healthy lifestyle decisions is increasingly influenced by nutrition. Premature aging is characterized by a variety of physiological changes that is resulting in weakening, loss of appetite, reduced bone and muscle mass, and weakened immune system. Clinical nutrition supports the nutritional needs of individuals, who are often impacted by malnutrition and a range of other disorders, contributing to the overall expansion of the clinical nutrition market growth.
Due to their slowing metabolism and inadequate food absorption, older people are embracing therapeutic nutrition. In addition, the increased prevalence of chronic diseases such as diabetes, cancer, osteoporosis, and cardiovascular problems among the global populace is a contributing factor to the surging requirements for clinical nutrition. As people age, they need specialized dietary therapy to address chronic health conditions.
By providing dietary supplements and medical foods, clinical nutrition is essential to the management and prevention of illness. Moreover, the growing incidence of obesity and related metabolic issues in the older population is supporting the expansion of the clinical nutrition industry. The World Health Organization (WHO) projects that by 2050, there will be 426 million adults over the age of 80.
Both consumers and healthcare experts are realizing how crucial food is to both preventing and treating ailments. To enhance patient outcomes, healthcare practitioners are beginning to understand how critical it is to assess, counsel, and intervene in nutrition during clinical practice. The identification of individuals who are susceptible to malnutrition or nutrient deficiencies requires the use of evidence-based recommendations, dietary intake evaluations, and nutritional screening methods.
The market forecast for clinical nutrition is also favorable due to the growing demand for functional meals, enhanced ready-to-drink (RTD) beverages, and customized nutrition plans. Food items, which strengthen the immune system, promote digestive health, and improve cognitive function are consumed by more people.
Individualized solutions to fulfill each person's dietary requirements and health goals are offered via medical nutrition treatment (MNT) and personalized nutrition. Technological developments, including nutrigenomics and metabolomics, help to expand knowledge of how genetic differences and metabolic pathways affect nutrient metabolism, dietary response, and chronic disease vulnerability.
Real-time feedback, remote monitoring, and personalized coaching are provided via wearable technologies, smartphone applications, and digital health platforms. The need for clinical nutrition is driven by technological advancements that empower people to actively manage their health through individualized diet plans and lifestyle changes.
A worldwide leader in protein and prebiotics, FrieslandCampina Ingredients introduced Nutri WheyTM ProHeat, a heat-stable whey protein, on November 23, 2023, specifically for the medical nutrition industry. Utilizing state-of-the-art microparticulation technology, FrieslandCampina Ingredients produced a whey protein component that is extremely heat-stable.
Clinical nutrition products are not as widely accessible in certain countries due to the unequal distribution of healthcare resources and services, especially in rural regions. The adoption of therapeutic nutrition products is occasionally becoming overshadowed by deeply ingrained cultural and traditional ideas in these countries that support the use of Ayurvedic and other traditional medical systems. A significant population is still getting their primary healthcare from traditional medical systems, which is hampering the clinical nutrition market size.
The market is forecasted to grow around the world as more people realize how important health is for a balanced and happy life. With health as the biggest treasure, people from several countries are investing in clinical nutrition diets, with major countries including the United States, China, Mexico, and South Korea. The United States market is forecasted to hold a strong clinical nutrition market share in North America.
“Presence of Educated Population with an Active Call for Balanced Nutrition”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 1.65 Billion |
| Growth Rate (2024 to 2034) | 5.7% CAGR |
| Projected Value (2034F) | US$ 2.87 Billion |
The United States market for clinical nutrition is becoming stronger day by day due to several factors. Firstly, a significant portion of the population in the United States is above the poverty line and possesses access to good education. This leads to higher awareness about the importance of nutrition and its impact on health.
The United States has a well-established healthcare system, which enables better access to clinical nutrition products and services. Moreover, the increasing prevalence of chronic diseases such as diabetes, cardiovascular issues, and obesity in the United States is leading to a growing demand for clinical nutrition solutions.
Growing Emphasis by More People on Health with Hectic Life
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 1.69 Billion |
| Growth Rate (2024 to 2034) | 5.3% CAGR |
| Projected Value (2034F) | US$ 2.85 Billion |
China is emerging as a key market in the East Asia region for clinical nutrition due to its huge population and the increasing focus on health. With a rapidly growing economy and a large population, more people in China are becoming increasingly aware of the importance of maintaining good health, especially in the face of hectic lifestyles and work pressures.
This awareness has led to a greater demand for clinical nutrition products and services to address several health concerns. Moreover, the rising incidence of chronic diseases and lifestyle-related health issues in China is further propelling the demand for clinical nutrition solutions to support overall health and well-being.
The market is segmented into several categories with suppliers dividing the market into segments including applications and product types. Among several product types, infant nutrition and parental nutrition are becoming prominent among people.
Parenteral Nutrition Segment Getting More Sales Opportunity than Infant Nutrition
| Attribute | Parenteral Nutrition |
|---|---|
| Segment Value (2024E) | US$ 9.35 Billion |
| Growth Rate (2024 to 2034) | 5.4% CAGR |
| Projected Value (2034F) | US$ 15.88 Billion |
The product type that is gaining more popularity globally among the masses is parenteral nutrition. This segment is experiencing increased sales opportunities compared to infant nutrition. Parenteral nutrition, which involves delivering nutrients intravenously, is increasingly adopted due to its ability to provide essential nutrients to individuals who are unable to consume food orally. The convenience and effectiveness of parenteral nutrition are contributing to its growing popularity among healthcare providers and patients worldwide.
Widespread Consumption of Clinical Nutrition for Metabolic Disorders
| Attribute | Metabolic Disorders |
|---|---|
| Segment Value (2024E) | US$ 3.44 Billion |
| Growth Rate (2024 to 2034) | 5.4% CAGR |
| Projected Value (2034F) | US$ 5.81 Billion |
Clinical nutrition is majorly employed in addressing metabolic disorders. Metabolic disorders significantly rely on clinical nutrition for managing the nutritional needs of affected individuals. Clinical nutrition plays a crucial role in helping patients with metabolic disorders meet their dietary requirements while managing their condition.
The tailored nutritional support provided through clinical nutrition interventions is essential for optimizing the health and well-being of individuals with metabolic disorders. As a result, clinical nutrition is a key component in the comprehensive management of metabolic disorders, making it a major application in the field of nutrition and healthcare. This is increasingly becoming a new clinical nutrition market trend.
Key players in the clinical nutrition market are focusing on bringing new products including clinical chemistry and clinical kits for home.
Fact.MR provides detailed information about the price points of key manufacturers in the clinical nutrition market positioned across the world, sales growth, production capacity, and speculative technological expansion, in this new market report.
How large is the clinical nutrition market in 2024?
The global market for clinical nutrition is valued at US$ 15.48 billion in 2024.
What is the demand outlook for clinical nutrition by 2034?
Worldwide sales of clinical nutrition are forecasted to reach US$ 25.94 billion by 2034.
At what rate are the sales of clinical nutrition evaluated to rise?
The market for clinical nutrition is projected to expand at a CAGR of 5.3% from 2024 to 2034.
What is the contribution of North America to global market revenue?
North America is evaluated to hold a 24.3% share of the global market by 2034.
What is the CAGR for clinical nutrition sales in Japan?
Sales of clinical nutrition in Japan are analyzed to rise at 5.8% CAGR through 2034.
How much share of the global market is projected to be held by the cancer segment?
The cancer segment is approximated to account for 21.9% of global market revenue by 2034.
Who are the leading manufacturers of clinical nutrition?
Abbott Nutrition, Pfizer Inc., and Bayer AG are some of the key market players.
Clinical Nutrition Market